Induction of apoptosis by HBI‐8000 in adult T‐cell leukemia/lymphoma is associated with activation of Bim and NLRP3
暂无分享,去创建一个
K. Yanagihara | D. Sasaki | N. Uno | Y. Morinaga | H. Hasegawa | Y. Miyazaki | R. Bissonnette | Y. Imaizumi | K. Tsuruda | Hideaki Kitanosono | H. Taniguchi | M. Gillings | K. Kosai
[1] Z. Ning,et al. Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.
[2] P. Krammer,et al. Tax contributes apoptosis resistance to HTLV-1-infected T cells via suppression of Bid and Bim expression , 2014, Cell Death and Disease.
[3] Xin Fu,et al. Discovery of an orally active subtype-selective HDAC inhibitor, chidamide, as an epigenetic modulator for cancer treatment , 2014 .
[4] K. Tsukasaki,et al. Heat shock protein 90 inhibitor NVP-AUY922 exerts potent activity against adult T-cell leukemia–lymphoma cells , 2014, Cancer science.
[5] G. Salvesen,et al. Regulated cell death: signaling and mechanisms. , 2014, Annual review of cell and developmental biology.
[6] K. Ishitsuka,et al. Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma. , 2014, The Lancet. Oncology.
[7] R. Johnstone,et al. Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders , 2014, Nature Reviews Drug Discovery.
[8] Kun Zhang,et al. Non-toxic dose chidamide synergistically enhances platinum-induced DNA damage responses and apoptosis in Non-Small-Cell lung cancer cells. , 2014, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[9] A. Tanaka,et al. HTLV-1 bZIP Factor Suppresses Apoptosis by Attenuating the Function of FoxO3a and Altering its Localization , 2014 .
[10] Xin Geng,et al. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection , 2013, Nature.
[11] Li-li Wang,et al. Increased PRAME-Specific CTL Killing of Acute Myeloid Leukemia Cells by Either a Novel Histone Deacetylase Inhibitor Chidamide Alone or Combined Treatment with Decitabine , 2013, PloS one.
[12] E. Latz,et al. Activation and regulation of the inflammasomes , 2013, Nature Reviews Immunology.
[13] K. Schroder,et al. AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC , 2013, Cell Death and Differentiation.
[14] K. Tobinai,et al. Biology and treatment of HTLV-1 associated T-cell lymphomas. , 2013, Best practice & research. Clinical haematology.
[15] G K Smyth,et al. HDAC inhibitors induce tumor-cell-selective pro-apoptotic transcriptional responses , 2013, Cell Death and Disease.
[16] M. Haneklaus,et al. Modulatory mechanisms controlling the NLRP3 inflammasome in inflammation: recent developments. , 2013, Current opinion in immunology.
[17] M. Ressing,et al. Inflammasomes and viruses: cellular defence versus viral offence. , 2012, The Journal of general virology.
[18] L. O’Neill,et al. Biochemical regulation of the inflammasome , 2012, Critical reviews in biochemistry and molecular biology.
[19] M. Fu,et al. Antitumor activity of Chidamide in hepatocellular carcinoma cell lines. , 2012, Molecular medicine reports.
[20] Ke Gong,et al. CS055 (Chidamide/HBI-8000), a novel histone deacetylase inhibitor, induces G1 arrest, ROS-dependent apoptosis and differentiation in human leukaemia cells. , 2012, The Biochemical journal.
[21] M. J. Newman,et al. Chidamide (CS055/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity , 2012, Cancer Chemotherapy and Pharmacology.
[22] R. Ueda,et al. Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] H. Mano,et al. Overexpression of enhancer of zeste homolog 2 with trimethylation of lysine 27 on histone H3 in adult T-cell leukemia/lymphoma as a target for epigenetic therapy , 2011, Haematologica.
[24] N. Mori,et al. LBH589, a deacetylase inhibitor, induces apoptosis in adult T-cell leukemia/lymphoma cells via activation of a novel RAIDD-caspase-2 pathway , 2011, Leukemia.
[25] Wei Zhao,et al. A novel histone deacetylase inhibitor Chidamide induces apoptosis of human colon cancer cells. , 2010, Biochemical and biophysical research communications.
[26] P. Choong,et al. Bim-targeted cancer therapy: A link between drug action and underlying molecular changes , 2009, Molecular Cancer Therapeutics.
[27] Yasuaki Yamada,et al. Activation of p53 by Nutlin-3a, an antagonist of MDM2, induces apoptosis and cellular senescence in adult T-cell leukemia cells , 2009, Leukemia.
[28] J. Ting,et al. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. , 2009, Immunity.
[29] T. Waldmann,et al. Effective treatment of a murine model of adult T-cell leukemia using depsipeptide and its combination with unmodified daclizumab directed toward CD25. , 2009, Blood.
[30] H. Koeffler,et al. Histone deacetylase inhibitors induce growth arrest and apoptosis of HTLV-1-infected T-cells via blockade of signaling by nuclear factor κB , 2008 .
[31] T. Inaba,et al. Cytokines direct the regulation of Bim mRNA stability by heat-shock cognate protein 70. , 2007, Molecular cell.
[32] H. Nagai,et al. Proviral status of HTLV-1 integrated into the host genomic DNA of adult T-cell leukemia cells. , 2005, Clinical and laboratory haematology.
[33] M. Tomonaga,et al. Sensitivity of adult T‐cell leukaemia lymphoma cells to tumour necrosis factor‐related apoptosis‐inducing ligand , 2005, British journal of haematology.
[34] S. Johansson,et al. β1‐Integrins induce phosphorylation of Akt on serine 473 independently of focal adhesion kinase and Src family kinases , 2004, EMBO reports.
[35] S. Iida,et al. Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[36] S. Grant,et al. The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1. , 2003, Cancer research.
[37] F. Martinon,et al. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. , 2002, Molecular cell.
[38] K. Matsushima,et al. Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells. , 2002, Blood.
[39] A. Strasser,et al. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes , 2002, Nature.
[40] M. Tomonaga,et al. Fas Gene Mutation in the Progression of Adult T Cell Leukemia , 1999, The Journal of experimental medicine.
[41] M. Shimoyama,et al. Diagnostic criteria and classification of clinical subtypes of adult T‐cell leukaemia‐lymphoma , 1991, British journal of haematology.
[42] Wei Zhao,et al. Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression , 2014, Laboratory Investigation.
[43] E. Miao,et al. Detection of pyroptosis by measuring released lactate dehydrogenase activity. , 2013, Methods in molecular biology.
[44] J. Wong,et al. Application of p21 and klf2 reporter gene assays to identify selective histone deacetylase inhibitors for cancer therapy. , 2011, Bioorganic & medicinal chemistry letters.
[45] H. Koeffler,et al. Histone deacetylase inhibitors induce growth arrest and apoptosis of HTLV-1-infected T-cells via blockade of signaling by nuclear factor kappaB. , 2008, Leukemia research.
[46] S. Grant,et al. The Histone Deacetylase Inhibitor MS-275 Promotes Differentiation or Apoptosis in Human Leukemia Cells through a Process Regulated by Generation of Reactive Oxygen Species and Induction of p 21 CIP 1 / WAF 1 1 , 2003 .
[47] M. Karin,et al. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. , 2000, Annual review of immunology.